SCHEMBL15028483

SCHEMBL15028483

CNC(CCN=[N+]=[N-])C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27041682 0.83 GGH (0.33) —
SCHEMBL27041677 0.83 GGH (0.33) —
SCHEMBL23747679 0.82 CTSL (0.31) —
SCHEMBL15028484 0.81 BMP1 (0.30) —
SCHEMBL17906289 0.77 CTSL (0.32) —
SCHEMBL14950991 0.75 FOLH1 (0.32) —
SCHEMBL15706851 0.75 FOLH1 (0.32) —
SCHEMBL15728239 0.74 — —
SCHEMBL18028046 0.73 NEU4 (0.32) —
SCHEMBL23589784 0.73 CTSL (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4268901-A2 IL-2R BETA-GAMMA C BINDING COMPOUNDS AND USES THEREOF Medikine, Inc. (US) 2023-11-01 — — EP disclosed
WO-2021158623-A1 IL-7Rαγc BINDING COMPOUNDS MEDIKINE, INC. (US) 2021-08-12 — — WO disclosed
WO-2012032181-A9 ANTIBODY DERIVATIVES ALLOZYNE, INC (US) 2013-06-13 — — WO disclosed
Send feedback